CAMP4 To Participate In Upcoming Investor Conferences
| Wells Fargo 21st Annual Healthcare Conference | |
| Format: | 1x1 meetings |
| Date and Time: | September 8, 2026 |
| Location: | Boston |
| Cantor Global Healthcare Conference | |
| Format: | Fireside chat and 1x1 meetings |
| Date and Time: | September 9, 2026, 1:00 p.m. ET |
| Location: | New York |
| Webcast Link: | Click Here |
Live webcasts can be accessed on the investor relations page of CAMP4's website at . A replay of the webcast will be archived on the CAMP4 website for 30 days following the presentation.
About CAMP4 Therapeutics
CAMP4 is developing disease-modifying treatments for a broad range of genetic diseases where amplifying healthy protein may offer therapeutic benefits. Our approach amplifies mRNA by harnessing a fundamental mechanism of how genes are controlled. To amplify mRNA, our therapeutic ASO drug candidates target regulatory RNAs (regRNAs), which act locally on transcription factors and are the master regulators of gene expression. CAMP4's proprietary RAP Platform® enables the mapping of regRNAs and generation of therapeutic candidates designed to target the regRNAs associated with genes underlying haploinsufficient and recessive partial loss-of-function disorders, of which there are more than 1,200, in which a modest increase in protein expression may have the potential to be clinically meaningful. For more information, visit camp4tx.com.
Contacts
Investor Relations:
Sara Michelmore
Milestone Advisors
...
Media:
Sofia Bermudez
LifeSci Communications
...
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment